Research programme: G protein-coupled receptor modulators - Axxam/Dompe
Latest Information Update: 01 Sep 2010
At a glance
- Originator Axxam; Dompe Farmaceutici
- Mechanism of Action G protein-coupled receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 01 May 2006 Preclinical trials in Undefined in Italy (unspecified route)